Almost every menopause resource assumes a cisgender woman with ovaries, a uterus, and a straightforward path from periods to no periods. Plenty of people do not fit that, and end up navigating hormonal change with no relevant information — or having to explain their own situation to a clinician who has never encountered it. This page covers what is known, what is genuinely uncertain, and what to ask.

Where we stand: Menova is an independent publication. We sell no hormones, we are not your doctor, and this is general education, not medical advice. This is an area where the research base is thin, and we will say so rather than fill gaps with confident guesses. Specialist gender care should lead these decisions.

Non-binary people and trans men with ovaries

If you have ovaries and are not on testosterone, the transition happens as it does for anyone with ovaries — the same cycle changes, hot flashes, sleep disruption and long-term bone and cardiovascular considerations described across this site.

If you are on testosterone, the picture is less documented. Testosterone commonly stops periods, which removes the cycle-based signal that the transition is usually read from — a similar problem to the one described in perimenopause while on hormonal contraception and after hysterectomy with ovaries kept. Symptoms rather than bleeding become the marker.

What is worth knowing:

  • Testosterone does not replace estrogen's role in bone. Some testosterone is converted to estrogen, but bone health should be actively monitored rather than assumed covered. Ask about a bone density scan and vitamin D; see bone health in menopause
  • Vaginal and pelvic tissue changes are common on testosterone and can be similar to those of menopause — dryness, discomfort, and urinary symptoms. Low-dose local estrogen is used in this situation by some clinicians precisely because it acts locally with minimal systemic absorption, which matters if you do not want systemic estrogen effects. That is a specialist conversation, not a decision to make from an article; see GSM and urinary changes and is vaginal estrogen safe
  • Cervical and other screening still applies if you have the relevant organs, regardless of your testosterone use or your documentation. This is one of the most consistently missed things in trans healthcare; see health screening in your 50s

After oophorectomy

Removal of both ovaries causes an immediate, abrupt drop in hormone production — surgical menopause — whoever it happens to. Where it occurs before the typical age of natural menopause, guidance for cisgender women generally recommends hormone replacement until around age 51, because a long span without those hormones carries bone and cardiovascular risk.

The same underlying physiology applies. What hormone to replace with, and at what level, is an individual decision made with the team managing your care — and the fact that most of the published guidance is written about cisgender women does not mean the bone and cardiovascular considerations stop applying to you. Our guide is at early and surgical menopause.

Trans women on long-term estrogen

There is no menopause in the ovarian sense, since there are no ovaries to decline. But two adjacent situations come up and are poorly covered:

Interrupted or reduced estrogen. Stopping, or being unable to access, estrogen can produce symptoms recognisable from this site — hot flashes, sleep disruption, mood change — because they follow estrogen withdrawal rather than anything specific to ovaries. Supply interruptions are unfortunately common, and it is worth knowing that these symptoms have a mechanism rather than being imagined.

Ageing on hormone therapy. Long-term estrogen use in trans women raises the same questions this site covers for anyone: clot risk and the route of administration, breast screening, bone density, and cardiovascular risk. Notably, the route matters here too — transdermal estrogen has not been shown to carry the clot risk associated with oral, and this is a recognised consideration in trans healthcare guidance as well; see HRT and blood clot risk.

Bone density is worth asking about specifically, particularly if there have been gaps in hormone therapy or if you have had orchiectomy.

The honest state of the evidence

Research on menopause and ageing in trans and non-binary people is limited. Long-term studies are few, and most menopause guidance was written without this population in mind.

What that means practically: the underlying physiology — what estrogen does for bone, what its withdrawal does to temperature regulation, what testosterone does to tissue — is reasonably understood and transfers. The population-specific data on long-term outcomes largely does not exist yet. Anyone giving you confident specifics beyond that is filling a gap that has not been filled.

Getting care that works

The practical difficulty is often not the medicine but the appointment. Things that help:

  • Ask for a clinician with relevant experience. Gender services, menopause specialists with an interest in this area, or a clinician willing to consult one. Both specialisms existing in one person is uncommon — asking them to talk to each other is reasonable
  • Bring the specifics. Which organs you have, what hormones you take and at what dose, surgical history with dates, and what has changed. This is exactly what our free printable visit prep sheet is for, and it saves you narrating it verbally
  • Ask what screening applies to you, based on organs rather than on how you are recorded. Screening invitations are frequently sent on the basis of the gender marker in a record, which means people are missed in both directions
  • You do not have to educate the room. If a clinician is not equipped, asking for a referral is a legitimate request rather than a confrontation

Our guides to finding a clinician who knows menopause and not being dismissed apply here, and the barriers are generally higher.

What transfers from the rest of this site

Most of it does, because most of it is not about identity:

Why this page exists

Because a symptom does not check who is having it. Someone searching for why they are waking drenched at 3am deserves an answer whether or not the standard resource was written with them in mind — and being unable to find one is a reason people delay care rather than a reason they do not need it.

The free 2-minute Menova self-check records symptoms rather than assumptions, and your answers never leave your device. No account, no card, not a diagnosis.

This article is general education, not medical advice or a diagnosis. Hormone therapy, screening, and surgical decisions require a licensed clinician, ideally one with experience in gender-affirming care. The evidence base in this area is limited, and individual circumstances vary widely.

Sources: WPATH Standards of Care, Endocrine Society Clinical Practice Guidelines, UCSF Transgender Care — Guidelines, and The Menopause Society.